Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-21

Clinical Trial Update: Effects of Atypical Antipsychotic and Valproate Combination Therapy on Glucose and Lipid Metabolism in Schizophrenia [NA]

View source ↗

Summary

Clinical trial update reporting completed results on the metabolic effects of combining an atypical antipsychotic with valproate on glucose and lipid metabolism…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Atypical antipsychotic (unspecified)
  • Valproate (valproate)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Insulin Resistance, Body Composition | NA | Status: COMPLETED